Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Luye Pharma Group Ltd. LYPHF

Full chart Compare
Set alert

Price alert · LYPHF

All alert types
0.27 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.27 Day range 0.27
0.2041 52-week range 0.395
YTD
-30.82%
1 year
+0.75%

Financial health

Altman Z-Score

1.04 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 5
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 1
  • P/E 4
  • P/B 5

Valuation

P/E 18.2×
FY 2016: 19.3×FY 2017: 16.3×FY 2018: 12.6×FY 2019: 11.4×FY 2020: 22.2×FY 2021: -113×FY 2022: 30.4×FY 2023: 21.7×FY 2024: 143×FY 2025: 18.2×
FY 2016 5y median 21.7× FY 2025
P/S 1.7×
FY 2016: 5.9×FY 2017: 4.2×FY 2018: 3.2×FY 2019: 2.6×FY 2020: 2.8×FY 2021: 3.2×FY 2022: 3.0×FY 2023: 1.8×FY 2024: 1.6×FY 2025: 1.7×
FY 2016 5y median 1.8× FY 2025
P/B 0.7×
FY 2016: 2.7×FY 2017: 2.3×FY 2018: 2.1×FY 2019: 1.8×FY 2020: 2.0×FY 2021: 1.9×FY 2022: 1.8×FY 2023: 0.9×FY 2024: 0.7×FY 2025: 0.7×
FY 2016 5y median 0.9× FY 2025
P/FCF 13.6×
FY 2016: 63.4×FY 2017: 46.9×FY 2018: -11.5×FY 2019: -11.3×FY 2020: -32.1×FY 2021: -12.1×FY 2022: 36.7×FY 2023: 26.3×FY 2024: -6.1×FY 2025: 13.6×
FY 2016 5y median 13.6× FY 2025
EV/EBITDA 7.6×
FY 2016: 16.2×FY 2017: 12.9×FY 2018: 10.7×FY 2019: 9.5×FY 2020: 11.6×FY 2021: 25.9×FY 2022: 13.7×FY 2023: 8.0×FY 2024: 6.8×FY 2025: 7.6×
FY 2016 5y median 8.0× FY 2025
EV/Sales 2.5×
FY 2016: 6.3×FY 2017: 4.6×FY 2018: 4.1×FY 2019: 3.5×FY 2020: 3.9×FY 2021: 4.5×FY 2022: 4.1×FY 2023: 2.7×FY 2024: 2.4×FY 2025: 2.5×
FY 2016 5y median 2.7× FY 2025
FCF Yield 7.3%
FY 2016: 1.6%FY 2017: 2.1%FY 2018: -8.7%FY 2019: -8.8%FY 2020: -3.1%FY 2021: -8.3%FY 2022: 2.7%FY 2023: 3.8%FY 2024: -16.3%FY 2025: 7.3%
FY 2016 5y median 2.7% FY 2025

Profitability

Gross Margin 66.0%
FY 2016: 81.7%FY 2017: 77.7%FY 2018: 78.3%FY 2019: 76.7%FY 2020: 72.0%FY 2021: 65.3%FY 2022: 69.2%FY 2023: 68.4%FY 2024: 66.7%FY 2025: 66.0%
FY 2016 5y median 66.7% FY 2025
Operating Margin 19.8%
FY 2016: 41.2%FY 2017: 28.6%FY 2018: 29.3%FY 2019: 31.3%FY 2020: 25.6%FY 2021: 7.4%FY 2022: 20.3%FY 2023: 16.7%FY 2024: 21.3%FY 2025: 19.8%
FY 2016 5y median 19.8% FY 2025
Net Margin 9.8%
FY 2016: 30.6%FY 2017: 25.7%FY 2018: 25.2%FY 2019: 23.1%FY 2020: 12.8%FY 2021: -2.8%FY 2022: 10.1%FY 2023: 8.7%FY 2024: 7.8%FY 2025: 9.8%
FY 2016 5y median 8.7% FY 2025
ROE 3.7%
FY 2016: 13.9%FY 2017: 14.5%FY 2018: 16.7%FY 2019: 15.9%FY 2020: 9.0%FY 2021: -1.7%FY 2022: 5.9%FY 2023: 4.3%FY 2024: 3.3%FY 2025: 3.7%
FY 2016 5y median 3.7% FY 2025
ROIC 3.1%
FY 2016: 13.1%FY 2017: 9.6%FY 2018: 9.2%FY 2019: 9.4%FY 2020: 5.6%FY 2021: 1.9%FY 2022: 4.9%FY 2023: 3.5%FY 2024: 3.8%FY 2025: 3.1%
FY 2016 5y median 3.5% FY 2025
ROA 1.8%
FY 2016: 9.7%FY 2017: 9.1%FY 2018: 7.4%FY 2019: 7.6%FY 2020: 3.4%FY 2021: -0.6%FY 2022: 2.5%FY 2023: 2.1%FY 2024: 1.6%FY 2025: 1.8%
FY 2016 5y median 1.8% FY 2025

Growth (YoY)

Revenue 1.4%
FY 2016: 13.8%FY 2017: 30.7%FY 2018: 35.6%FY 2019: 22.9%FY 2020: -12.9%FY 2021: -6.1%FY 2022: 15.0%FY 2023: 2.7%FY 2024: -1.3%FY 2025: 1.4%
FY 2016 FY 2025
Operating Income -5.6%
FY 2016: 9.0%FY 2017: -9.3%FY 2018: 39.0%FY 2019: 31.2%FY 2020: -28.7%FY 2021: -72.7%FY 2022: 214.0%FY 2023: -15.3%FY 2024: 25.5%FY 2025: -5.6%
FY 2016 FY 2025
EPS (diluted) 757.1%
FY 2016: 17.4%FY 2017: 11.1%FY 2018: 33.3%FY 2019: 15.0%FY 2020: -52.2%FY 2021: -119.1%FY 2022: 504.8%FY 2023: -17.6%FY 2024: -87.5%FY 2025: 757.1%
FY 2016 FY 2025
Free Cash Flow 150.7%
FY 2016: 46.2%FY 2017: 24.2%FY 2018: -524.6%FY 2019: -2.7%FY 2020: 67.1%FY 2021: -179.4%FY 2022: 136.1%FY 2023: -12.2%FY 2024: -458.1%FY 2025: 150.7%
FY 2016 FY 2025

Financial Health

Current Ratio 1.5×
FY 2016: 2.2×FY 2017: 1.7×FY 2018: 1.1×FY 2019: 1.7×FY 2020: 1.4×FY 2021: 1.4×FY 2022: 1.1×FY 2023: 1.3×FY 2024: 1.2×FY 2025: 1.5×
FY 2016 5y median 1.3× FY 2025
Quick Ratio 1.4×
FY 2016: 2.0×FY 2017: 1.6×FY 2018: 1.0×FY 2019: 1.6×FY 2020: 1.3×FY 2021: 1.3×FY 2022: 1.1×FY 2023: 1.2×FY 2024: 1.2×FY 2025: 1.4×
FY 2016 5y median 1.2× FY 2025
Debt / Equity 0.6×
FY 2016: 0.3×FY 2017: 0.4×FY 2018: 0.8×FY 2019: 0.9×FY 2020: 1.3×FY 2021: 1.1×FY 2022: 0.9×FY 2023: 0.7×FY 2024: 0.7×FY 2025: 0.6×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA 2.4×
FY 2016: 1.1×FY 2017: 1.2×FY 2018: 2.3×FY 2019: 2.4×FY 2020: 3.3×FY 2021: 7.8×FY 2022: 3.7×FY 2023: 2.5×FY 2024: 2.5×FY 2025: 2.4×
FY 2016 5y median 2.5× FY 2025
Interest Coverage 1.8×
FY 2016: 39.6×FY 2017: 21.6×FY 2018: 8.9×FY 2019: 7.2×FY 2020: 3.3×FY 2021: 1.0×FY 2022: 2.6×FY 2023: 1.5×FY 2024: 2.3×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.6%FY 2017: 1.3%FY 2018: 1.8%FY 2019: 2.3%FY 2020: 1.1%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 12.0%FY 2017: 21.7%FY 2018: 22.2%FY 2019: 25.7%FY 2020: 24.8%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31